STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
Bactiguard Holding (STO:BACTIB)
The Annual General Meeting in Bactiguard Holding AB (publ) will be held on Thursday 21 May, 2015 in Stockholm.
At the Annual General Meeting (AGM) in 2014, it was resolved that the Nomination Committee in Bactiguard Holding AB (publ) shall be formed in a process where the Chairman of the Board contacts the three largest shareholders, based on voting rights according to the share register maintained by Euroclear Sweden AB on 31 August, who each have the right to appoint a member. The appointed members will, together with the Chairman of the Board, constitute the Nomination Committee.
The Nomination Committee for the 2015 AGM in Batiguard Holding AB (publ) consists of the following members:
Christian Kinch, Chairman of the Board of Directors, appointed by KK Invest AB
Michael Wigge, appointed by Bactiguard
B.V Frank Larsson, appointed by Handelsbanken Fonder AB
The Nomination Committee will make proposals to the AGM 2015 concerning the election of a Chairman for the AGM, the Chairman and other members of the Board of Directors, as well as auditors. The Nomination Committee will also make proposals regarding remuneration to the Board of Directors, including any separate remuneration for committee work, as well as remuneration to the auditors. Further, the Nomination Committee will make a proposal regarding principles for forming the Nomination Committee for the AGM in 2016.
Shareholders who wish to make proposals to the Nomination Committee can do so by writing to the Nomination Committee under the following address:
Bactiguard Holding AB (publ)
102 42 Stockholm
Proposals can also be sent by email to the following address:
In order for the Nomination Committee to be able to address proposals in a contructive manner, they should have been received by January 16, 2015.
The proposals of the Nomination Committee will be presented in the invitation to the AGM and at the company’s website.
Bactiguard is a Swedish medtech company with a business concept of preventing healthcare-related infections, reducing the use of antibiotics and saving lives by developing and supplying infection prevention solutions for the healthcare industry. The company’s patented coating prevents healthcare-associated infections by reducing bacterial adhesion and growth on medical devices. Bactiguard®-coated urinary catheters are market leading in the US and Japan, and in recent years the company has developed its own product portfolio of coated catheters for the urinary and respiratory tract and the blood stream. Bactiguard is currently in a strong expansion phase, focused on new markets in the EU, Middle East, Asia and South America. The company reported sales of approximately SEK 130 million in 2013 and has 60 employees, headquarters in Stockholm and production facilities in Sweden and Malaysia. The Bactiguard share is listed on Nasdaq Stockholm. Read more at: www.bactiguard.se
This information was brought to you by Cision http://news.cision.com